The American Medical Association (AMA) Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson (Lexiscan) and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe. The policy was adopted at the AMA 2022 meeting last week. Many cardiologists prefer to use…